Stocks · Health care · Biological Products, (No Diagnostic Substances)

Revolution Medicines, Inc.

RVMD Clue Score22
United States Fiscal year ends December CIK 0001628171 Results filed 4 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Thilo Schroeder
5 Dec 2024
Director
Buy indirect
760,869
$46.00
$35.00M
Thilo Schroeder
5 Dec 2024
Director
Buy indirect
543,478
$46.00
$25.00M
Showing 250 of 518 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 373
Amendments (4/A) skipped 9
Filings about a different issuer 0
Unreadable filings 0
Joint filings 12
Sales on a Rule 10b5-1 plan 119
Sales straight out of an exercise 253
Sales at will 95
Transactions with no price 1
Shares from compensation/vesting 35,863,308
Sales filed before the plan box existed 81
History held since 14 Feb 2020